Rigid thinking about muscular rigidity and the other motor manifestations of Parkinson’s Disease (PD) can distort our appreciation of the significant non-motor manifestations of the condition, such as autonomic and cognitive dysfunction, sleep disturbances and pain.
Rigid thinking about the failure to prevent progressive neurodegeneration with present treatments can lead to despair for both patients and their physicians.
Rigid thinking is not welcome in the Doctors’ Lounge.
You are invited to spend an evening during Parkinson’s Awareness Month thinking differently about the future.
Think: Precision medicine. Focused ultrasound. Innovative surgeries. Manipulation of the microbiome and mitochondria. Neuroprotectants. Even vaccinations!
Think: hope.
Please join us as our distinguished guide for the evening broadens our horizons on future therapies for PD.
Dr. Susan Fox MB, ChB, MRCP(UK), PhD is Head of the Division of Neurology, University Health Network and Sinai Health Systems; holds the Krembil Family Chair of Neurology; Professor of Neurology, University of Toronto and Associate Director of the Movement Disorder Clinic, Toronto Western Hospital. Dr. Fox is Chair of the Pan-American section of the International Parkinson and Movement Disorder Society (MDS) (2021-23). She has served on committees, grant review and advisory boards for MDS, NIH, CIHR, Michael J Fox Foundation for Parkinson research and DMRF among others. Dr. Fox has over 20 years’ experience in preclinical models of Parkinson’s disease and translational studies of novel pharmacological therapies for Parkinson’s disease and other movement disorders such as dystonia. She has published over 170 peer-reviewed papers, reviews and book chapters in the field and is a regular speaker at national and international conferences.
No comments:
Post a Comment